A real-world study on the utility of regular rituximab treatment for neuromyelitis optica spectrum disorder. Chen X, Wang R, Li R, Hu S, et al. J Neurol 2025;272:194.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chen X, Wang R, Li R, Hu S, et al. A real-world study on the utility of regular rituximab treatment for neuromyelitis optica spectrum disorder. J Neurol 2025;272:194.
PMID: 39932569